Sanofi Biosurgery - Sanofi Aventis
Sanofi Biosurgery Inc. develops and markets surgical devices and biologics for osteoarthritis pain relief, adhesion reduction, cartilage repair, and severe burn treatment.
Its products include Synvisc, Synvisc-One (hylan G-F 20), Carticel (autologous cultured chondrocytes), MACI (Matrix-induced Autologous Chondrocyte Implantation), Seprafilm, and Epicel (cultured epidermal autografts).
Sanofi Biosurgery Inc. was formerly known as Genzyme Biosurgery Corporation.
As a result of acquisition of Genzyme Biosurgery Corporation by Sanofi, Genzyme Biosurgery Corporation name was changed.
The company was founded in 2000 and is based in Cambridge, Massachusetts. Sanofi Biosurgery Inc. operates as a subsidiary of Sanofi